Editor's Corner

Quest Diagnostics teams up with CDC for hepatitis research initiative

Quest Diagnostics inked a deal with the Centers for Disease Control and Prevention (CDC) to improve screening, diagnosis and treatment for four strains of viral hepatitis in the U.S., expanding on a previous collaboration and giving the company a boost as it continues to restructure and restore revenue growth.

Myriad settles patent feud with Invitae, Pathway Genomics over BRCA technology

Myriad Genetics is throwing in the towel in its fight to stop other companies from offering diagnostic tests that spot specific genes known to be associated with a higher risk of breast cancer.

HTG Molecular Diagnostics scores $18M as it mulls IPO

HTG Molecular Diagnostics hinted around plans for a $60 million IPO in December, saying that it would use funds to boost R&D and commercialization for its high-volume genomic testing platform. Now, the Tucson, AZ-based company is adding more than $18 million to its pot as it continues to mull a public offering.

Roche nabs FDA OK for drug-resistant bacteria test

Roche got an FDA green light for its drug-resistant MRSA/SA test, chalking up another regulatory win and expanding the company's offerings on its cobas 4800 system.

Claritas Genomics brings in $15M Series B for pediatric diagnostics

Boston Children's Hospital spinoff Claritas Genomics has roped in $15 million in capital in a Series B round to help launch a new slate of next-generation sequencing-based tests for the diagnosis of pediatric genetic disorders. The Cambridge, MA-based company also plans to use the cash influx to continue to build its network of clinical pediatric disease experts.


From Our Sister Sites


As the med tech industry homes in on next-generation devices for peripheral artery disease, medical experts are questioning the necessity of procedures to treat the disease, pointing to large Medicare payments made to physicians performing the operations.


Scientists in Florida have found a virus in ticks that is connected to hemorrhagic fever, which was thought to have disappeared globally more than 40 years ago.